Novartis in Regenerex Stem Cell Deal to Ease Kidney Transplants – Bloomberg
|
Novartis in Regenerex Stem Cell Deal to Ease Kidney Transplants
Bloomberg Novartis AG (NOVN) entered a collaboration with Regenerex LLC, gaining access to stem cell technology that may help kidney transplant patients avoid taking anti-rejection medicine for life. Regenerex, a startup biology company based in Louisville, … |
